Sensus Healthcare Brings Groundbreaking SRT-100 Vision System to Israel’s Largest Hospital for Skin Cancer and Keloid Treatment

BOCA RATON, Fla.Oct. 17, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy (IGSRT), today announced that the Company has shipped  its third SRT-100 Vision™system to Israel, with the newest unit located at the Sheba Medical Center in Tel HaShomer, near Tel Aviv. The other two previously installed units reside at the Ichilov Hospital in Tel Aviv and Beilinson Hospital / Rabin Medical Center in Petah Tikva.

Read the full press release here.

Share to:

Contact Us

Fill out the form below to find out more!